Journal Title：Acta Neurologica Scandinavica

Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal's scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as 'Clinical commentaries' not exceeding two printed pages, as will 'Clinical commentaries' of sufficient general interest. Debate within the speciality is encouraged in the form of 'Letters to the editor'. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.

Acta Neurologica Scandinavica 旨在發表具有高科學質量的論文，這些論文代表神經科學領域的原創臨床、診斷或實驗工作。該期刊的范圍是充當傳播促進該學科領域科學或實踐的信息的國際論壇。歡迎英文論文，尤其是那些帶來新知識和觀察結果的論文，這些新知識和觀察結果來自治療或技術在對抗廣泛的神經系統疾病和神經退行性疾病中的應用。有關基礎神經科學的相關文章將發表，以擴展對此類疾病的現有理解。將優先考慮對專題的評論。由于其重要性和及時性而需要快速發表的論文將作為不超過兩頁印刷頁的“臨床評論”收錄，具有足夠普遍興趣的“臨床評論”也將收錄。鼓勵以“致編輯的信”的形式在專業范圍內進行辯論。所有屬于該期刊總體范圍的提交稿件都將由適當合格的審稿人進行評估。

Acta Neurologica Scandinavica創刊于1961年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵蓋醫學 - 臨床神經學全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 偏慢,4-8周 ，影響因子指數2.9，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。